Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Neuvonen

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2025
Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitroWilma Kiander, Hatam Rashidpour, Mikko Gynther, et al.
International Journal of Obesity (2005)|January 4, 2026
Distinct fasting and postprandial bile acid responses following Roux-en-Y and one-anastomosis gastric bypassMatti Jänis, Tuure Saarinen, Jari E Karppinen, et al.
Clinical Pharmacology and Therapeutics|July 13, 2018
CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or PrasugrelMikko T Holmberg, Aleksi Tornio, Maria Paile-Hyvärinen, et al.
Anesthesiology|May 7, 2009
Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodoneTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Pharmacogenetics and Genomics|April 24, 2009
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humansXiaoqiang Xiang, Yi Han, Mikko Neuvonen, et al.
European Journal of Clinical Pharmacology|October 27, 2012
Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interactionNora M Hagelberg, Tuukka Saarikoski, Teijo I Saari, et al.
Clinical and Translational Science|May 27, 2020
Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate RosuvastatinMinna Lehtisalo, Jenni E Keskitalo, Aleksi Tornio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2021
Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of StatinsAnne M Filppula, Päivi Hirvensalo, Heli Parviainen, et al.
Hepatology Communications|February 8, 2021
Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile CompositionVille Männistö, Dorota Kaminska, Pirjo Käkelä, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast PharmacokineticsPäivi Hirvensalo, Aleksi Tornio, Mikko Neuvonen, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2025
Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitroWilma Kiander, Hatam Rashidpour, Mikko Gynther, et al.
International Journal of Obesity (2005)|January 4, 2026
Distinct fasting and postprandial bile acid responses following Roux-en-Y and one-anastomosis gastric bypassMatti Jänis, Tuure Saarinen, Jari E Karppinen, et al.
Clinical Pharmacology and Therapeutics|July 13, 2018
CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or PrasugrelMikko T Holmberg, Aleksi Tornio, Maria Paile-Hyvärinen, et al.
Anesthesiology|May 7, 2009
Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodoneTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Pharmacogenetics and Genomics|April 24, 2009
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humansXiaoqiang Xiang, Yi Han, Mikko Neuvonen, et al.
European Journal of Clinical Pharmacology|October 27, 2012
Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interactionNora M Hagelberg, Tuukka Saarikoski, Teijo I Saari, et al.
Clinical and Translational Science|May 27, 2020
Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate RosuvastatinMinna Lehtisalo, Jenni E Keskitalo, Aleksi Tornio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2021
Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of StatinsAnne M Filppula, Päivi Hirvensalo, Heli Parviainen, et al.
Hepatology Communications|February 8, 2021
Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile CompositionVille Männistö, Dorota Kaminska, Pirjo Käkelä, et al.
Clinical Pharmacology and Therapeutics|September 24, 2017
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast PharmacokineticsPäivi Hirvensalo, Aleksi Tornio, Mikko Neuvonen, et al.
Pageof 11